{"DataElement":{"publicId":"6964658","version":"2","preferredName":"Analysis Method","preferredDefinition":"Method of the test or examination.","longName":"LBANMETH","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6962763","version":"1","preferredName":"Laboratory Data Domain Analysis Method","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data._A means, manner of procedure, or systematic course of actions that are performed in order to examine and interpret an event or entity.","longName":"6401816v1.0:6962761v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6401816","version":"1","preferredName":"Laboratory Data Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.","longName":"C49592","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Data Domain","conceptCode":"C49592","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to laboratory data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7393E896-CD8C-74C0-E053-F662850A1D4C","latestVersionIndicator":"Yes","beginDate":"2018-08-16","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-16","modifiedBy":"ONEDATA","dateModified":"2018-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6962761","version":"1","preferredName":"Analysis Method","preferredDefinition":"A means, manner of procedure, or systematic course of actions that are performed in order to examine and interpret an event or entity.","longName":"C117039","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Analysis Method","conceptCode":"C117039","definition":"A means, manner of procedure, or systematic course of actions that are performed in order to examine and interpret an event or entity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94057A26-0EAC-16F7-E053-F662850AF404","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94057A26-0EBD-16F7-E053-F662850AF404","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"TAYLORT","dateModified":"2019-10-07","changeDescription":"10-3-19 Created for Theradex/custom CDISC request; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6964635","version":"2","preferredName":"CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology Clinical Study Sponsor Defined Name","preferredDefinition":"Terminology associated with the laboratory analytical method calculation formula codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM)._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"LBANMET_SPD","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SCHWARTZ METHOD FOR CHILDREN FORMULA","valueDescription":"Schwartz Method For Children Formula","ValueMeaning":{"publicId":"6964637","version":"1","preferredName":"Schwartz Method For Children Formula","longName":"6964637","preferredDefinition":"A formula to estimate glomerular filtration rate in children that takes into account age, height, and serum creatinine. eGFR (mL/min/1.73 m2) = k x Height (cm)/Serum creatinine (mg/dL) where k=0.33 for pre-term babies, 0.45 for full-term babies and 0.55 for girls ages 1-13 or 0.70 for boys ages 1-13. (Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985 Mar;106(3):522-6.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Schwartz Method For Children Formula","conceptCode":"C161348","definition":"A formula to estimate glomerular filtration rate in children that takes into account age, height, and serum creatinine. eGFR (mL/min/1.73 m2) = k x Height (cm)/Serum creatinine (mg/dL) where k=0.33 for pre-term babies, 0.45 for full-term babies and 0.55 for girls ages 1-13 or 0.70 for boys ages 1-13. (Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr. 1985 Mar;106(3):522-6.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-80EE-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA50-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"MDRD ENZYMATIC JAPANESE FORMULA","valueDescription":"MDRD Enzymatic Japanese Formula","ValueMeaning":{"publicId":"6964639","version":"1","preferredName":"MDRD Enzymatic Japanese Formula","longName":"6964639","preferredDefinition":"A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (ml/min/1.73m2) = 194 x PD93 power^-1.094 x Age power^- 0.287 x Sex; where PD93 = Serum Cr (mg/dL), Sex = 1.00 for male and 0.739 for female. (Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MDRD Enzymatic Japanese Formula","conceptCode":"C161347","definition":"A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (ml/min/1.73m2) = 194 x PD93 power^-1.094 x Age power^- 0.287 x Sex; where PD93 = Serum Cr (mg/dL), Sex = 1.00 for male and 0.739 for female. (Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-8114-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA5A-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"MDRD ENZYMATIC FORMULA","valueDescription":"MDRD Enzymatic Formula","ValueMeaning":{"publicId":"6964641","version":"1","preferredName":"MDRD Enzymatic Formula","longName":"6964641","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine. eGFR (mL/min/1.73 m2)=175 x (serum Cr [conv mg/dL])^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for conventional units. eGFR=175 x (serum Cr [SI UMOL/L]/88.4)^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for SI units. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MDRD Enzymatic Formula","conceptCode":"C161346","definition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine. eGFR (mL/min/1.73 m2)=175 x (serum Cr [conv mg/dL])^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for conventional units. eGFR=175 x (serum Cr [SI UMOL/L]/88.4)^-1.154 x (Age)^ -0.203 x (0.742 if female) x (1.212 if black), for SI units. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-813A-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA64-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"MDRD 6 VARIABLE FORMULA","valueDescription":"MDRD 6 Variable Formula","ValueMeaning":{"publicId":"6964643","version":"1","preferredName":"MDRD 6 Variable Formula","longName":"6964643","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine, serum urea nitrogen, and albumin. eGFR (mL/min/1.73 m2) = 170 x (SCr/88.4)^-0.999 x age^-0.176 x (SU x 2.78)^-0.170 x albumin^0.318 x (0.762, if female) x (1.18, if African American). (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MDRD 6 Variable Formula","conceptCode":"C161345","definition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine, serum urea nitrogen, and albumin. eGFR (mL/min/1.73 m2) = 170 x (SCr/88.4)^-0.999 x age^-0.176 x (SU x 2.78)^-0.170 x albumin^0.318 x (0.762, if female) x (1.18, if African American). (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-8160-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA6E-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"MDRD 5 VARIABLE FORMULA","valueDescription":"MDRD 5 Variable Formula","ValueMeaning":{"publicId":"6964645","version":"1","preferredName":"MDRD 5 Variable Formula","longName":"6964645","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine and serum urea nitrogen. eGFR (mL/min/1.73 m = 270 x creatinine (mg/dl)^-1.007 x age^-0.180 x 1.178 (if black) x 0.762 (if female) x serum urea nitrogen^-0.169. (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MDRD 5 Variable Formula","conceptCode":"C161344","definition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, serum creatinine and serum urea nitrogen. eGFR (mL/min/1.73 m = 270 x creatinine (mg/dl)^-1.007 x age^-0.180 x 1.178 (if black) x 0.762 (if female) x serum urea nitrogen^-0.169. (Levey AS, Greene T, Kusek JW, Beck GJ, MDRD study group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-8186-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA78-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"MDRD 4 VARIABLE FORMULA","valueDescription":"MDRD 4 Variable Formula","ValueMeaning":{"publicId":"6964647","version":"1","preferredName":"MDRD 4 Variable Formula","longName":"6964647","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine (Scr). eGFR (mL/min/1.73 m2) = 186 x (Scr)^-1.154 x (Age)^-0.203 x (0.742 if female) x (1.210 if African American). (Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MDRD 4 Variable Formula","conceptCode":"C161343","definition":"A formula to estimate glomerular filtration rate that takes into account age, sex, race, and serum creatinine (Scr). eGFR (mL/min/1.73 m2) = 186 x (Scr)^-1.154 x (Age)^-0.203 x (0.742 if female) x (1.210 if African American). (Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-81AC-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA82-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"COCKCROFT-GAULT FORMULA","valueDescription":"Cockcroft-Gault Formula","ValueMeaning":{"publicId":"6964649","version":"1","preferredName":"Cockcroft-Gault Formula","longName":"6964649","preferredDefinition":"A formula to estimate creatinine clearance that takes into account sex, age, weight, and serum creatinine (SCr). CCr=(140 - Age) x Wgt (Kg) / 72xCrt (mg/dL) x 1 (if M) or 0.85 (if F), for conventional units. CCr=(140 - Age) x Wgt (Kg) / 72xCrt (MCMOL/L) x 88.4 x 1 (if M) or 0.85 (if F) [If Wgt is in lbs; Wgt (Kg) = Wgt (lbs) x 0.45], for SI units. (Cockcroft, D.W. and M.H. Gault. Prediction of creatinine clearance from serum creatinine. Nephron. 1976. 16(1):31-41.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cockcroft-Gault Formula","conceptCode":"C161342","definition":"A formula to estimate creatinine clearance that takes into account sex, age, weight, and serum creatinine (SCr). CCr=(140 - Age) x Wgt (Kg) / 72xCrt (mg/dL) x 1 (if M) or 0.85 (if F), for conventional units. CCr=(140 - Age) x Wgt (Kg) / 72xCrt (MCMOL/L) x 88.4 x 1 (if M) or 0.85 (if F) [If Wgt is in lbs; Wgt (Kg) = Wgt (lbs) x 0.45], for SI units. (Cockcroft, D.W. and M.H. Gault. Prediction of creatinine clearance from serum creatinine. Nephron. 1976. 16(1):31-41.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-81D2-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA8C-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"CKD-EPI FORMULA","valueDescription":"CKD-EPI Formula","ValueMeaning":{"publicId":"6964651","version":"1","preferredName":"CKD-EPI Formula","longName":"6964651","preferredDefinition":"An unspecified formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CKD-EPI Formula","conceptCode":"C161341","definition":"An unspecified formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-81F8-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CA96-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"CKD-EPI CYSTATIN C FORMULA","valueDescription":"CKD-EPI Cystatin C Formula","ValueMeaning":{"publicId":"6964653","version":"1","preferredName":"CKD-EPI Cystatin C Formula","longName":"6964653","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=133 x min(Scys/0.8, 1)^-0.499 x max (Scys/0.8, 1)^-1.328 x 0.996^Age x 0.932 [if female]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CKD-EPI Cystatin C Formula","conceptCode":"C161339","definition":"A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=133 x min(Scys/0.8, 1)^-0.499 x max (Scys/0.8, 1)^-1.328 x 0.996^Age x 0.932 [if female]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-821E-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CAA0-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"CKD-EPI CREATININE FORMULA","valueDescription":"CKD-EPI Creatinine Formula","ValueMeaning":{"publicId":"6964655","version":"1","preferredName":"CKD-EPI Creatinine Formula","longName":"6964655","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum creatinine (SCr). eGFR(mL/min/1.73 m2)=141 x min(SCr/k, 1)^a x max(SCr/k, 1)^-1.209 x 0.993^Age x 1.018 [if female] x 1.159 [if black] where: SCr is in mg/dL; k=0.7 for Female and 0.9 for Male; a=-0.329 for female and -0.411 for male. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CKD-EPI Creatinine Formula","conceptCode":"C161338","definition":"A formula to estimate glomerular filtration rate that takes into account sex, age, race, and serum creatinine (SCr). eGFR(mL/min/1.73 m2)=141 x min(SCr/k, 1)^a x max(SCr/k, 1)^-1.209 x 0.993^Age x 1.018 [if female] x 1.159 [if black] where: SCr is in mg/dL; k=0.7 for Female and 0.9 for Male; a=-0.329 for female and -0.411 for male. (Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-8244-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CAAA-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"CKD-EPI CREATININE-CYSTATIN C FORMULA","valueDescription":"CKD-EPI Creatinine-Cystatin C Formula","ValueMeaning":{"publicId":"6964657","version":"1","preferredName":"CKD-EPI Creatinine-Cystatin C Formula","longName":"6964657","preferredDefinition":"A formula to estimate glomerular filtration rate that takes into account sex, age, race, serum creatinine (SCr) and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=135 x min(SCr/k, 1)a x max(SCr/k, 1)-0.601 x min(Scys/0.8, 1)-0.375 x max(Scys/0.8, 1)-0.711 x 0.995^Age x 0.969 [if female] x 1.08 [if black]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CKD-EPI Creatinine-Cystatin C Formula","conceptCode":"C161340","definition":"A formula to estimate glomerular filtration rate that takes into account sex, age, race, serum creatinine (SCr) and serum cystatin C (Scys). eGFR(mL/min/1.73 m2)=135 x min(SCr/k, 1)a x max(SCr/k, 1)-0.601 x min(Scys/0.8, 1)-0.375 x max(Scys/0.8, 1)-0.711 x 0.995^Age x 0.969 [if female] x 1.08 [if black]. (Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94086349-826A-0DC2-E053-F662850A4D1F","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-03","modifiedBy":"ONEDATA","dateModified":"2019-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CAB4-37D0-E053-F662850A69E3","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"COCKCROFT-GAULT FORMULA UTILIZING TOTAL BODY WEIGHT","valueDescription":"Cockcroft-Gault Formula Utilizing Total Body Weight","ValueMeaning":{"publicId":"7071936","version":"1","preferredName":"Cockcroft-Gault Formula Utilizing Total Body Weight","longName":"7071936","preferredDefinition":"A variation of the Cockcroft-Gault formula to predict creatinine clearance that uses total body weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cockcroft-Gault Formula Utilizing Total Body Weight","conceptCode":"C166370","definition":"A variation of the Cockcroft-Gault formula to predict creatinine clearance that uses total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9909C965-BCCF-6DD1-E053-F662850AAC34","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-12-06","modifiedBy":"ONEDATA","dateModified":"2019-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CABE-37D0-E053-F662850A69E3","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"COCKCROFT-GAULT FORMULA UTILIZING IDEAL BODY WEIGHT","valueDescription":"Cockcroft-Gault Formula Utilizing Ideal Body Weight","ValueMeaning":{"publicId":"7071937","version":"1","preferredName":"Cockcroft-Gault Formula Utilizing Ideal Body Weight","longName":"7071937","preferredDefinition":"A variation of the Cockcroft-Gault formula to predict creatinine clearance that uses an idealized body weight. For males, ideal body weight=50 kg + 2.3 kg for each inch over 5 feet; for females, 45.5 kg + 2.3 kg for each inch over 5 feet.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cockcroft-Gault Formula Utilizing Ideal Body Weight","conceptCode":"C166369","definition":"A variation of the Cockcroft-Gault formula to predict creatinine clearance that uses an idealized body weight. For males, ideal body weight=50 kg + 2.3 kg for each inch over 5 feet; for females, 45.5 kg + 2.3 kg for each inch over 5 feet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9909C965-BCF4-6DD1-E053-F662850AAC34","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-12-06","modifiedBy":"ONEDATA","dateModified":"2019-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CAC8-37D0-E053-F662850A69E3","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"COCKCROFT-GAULT FORMULA UTILIZING ADJUSTED BODY WEIGHT","valueDescription":"Cockcroft-Gault Formula Utilizing Adjusted Body Weight","ValueMeaning":{"publicId":"7071938","version":"1","preferredName":"Cockcroft-Gault Formula Utilizing Adjusted Body Weight","longName":"7071938","preferredDefinition":"A variation of the Cockcroft-Gault formula to predict creatinine clearance that uses an adjusted body weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cockcroft-Gault Formula Utilizing Adjusted Body Weight","conceptCode":"C166368","definition":"A variation of the Cockcroft-Gault formula to predict creatinine clearance that uses an adjusted body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9909C965-BD19-6DD1-E053-F662850AAC34","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-12-06","modifiedBy":"ONEDATA","dateModified":"2019-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CAD2-37D0-E053-F662850A69E3","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"SANAKA","valueDescription":"Sanaka Equation for Creatinine Clearance","ValueMeaning":{"publicId":"7071939","version":"1","preferredName":"Sanaka Equation for Creatinine Clearance","longName":"7071939","preferredDefinition":"A formula to predict creatinine clearance (CCr, ml/min) in the elderly with chronic muscle atrophy using serum albumin (Alb, g/dl). For males: ABW (19 Alb +32) / 100 Scr; for females: ABW (13 Alb +29) / 100 Scr; where: Alb = plasma albumin level (g/dL); Scr = serum creatinine (mg/dL); ABW = actual body weight in Kg","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sanaka Equation for Creatinine Clearance","conceptCode":"C166367","definition":"A formula to predict creatinine clearance (CCr, ml/min) in the elderly with chronic muscle atrophy using serum albumin (Alb, g/dl). For males: ABW (19 Alb +32) / 100 Scr; for females: ABW (13 Alb +29) / 100 Scr; where: Alb = plasma albumin level (g/dL); Scr = serum creatinine (mg/dL); ABW = actual body weight in Kg","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9909C965-BD3E-6DD1-E053-F662850AAC34","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-12-06","modifiedBy":"ONEDATA","dateModified":"2019-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CADC-37D0-E053-F662850A69E3","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"JELIFFE","valueDescription":"Jelliffe Equation for Creatinine Clearance","ValueMeaning":{"publicId":"7071940","version":"1","preferredName":"Jelliffe Equation for Creatinine Clearance","longName":"7071940","preferredDefinition":"A formula for evaluating renal function for adults with normal muscle mass and Scr less than 5 mg/dL. For males: 98 - 0.8 (A - 20) / Scr; for females: 88 - 0.7 (A - 20) / Scr; where A = age in yrs; CLcr = creatinine clearance in mL/min/1.73 m^2","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Jelliffe Equation for Creatinine Clearance","conceptCode":"C166364","definition":"A formula for evaluating renal function for adults with normal muscle mass and Scr less than 5 mg/dL. For males: 98 - 0.8 (A - 20) / Scr; for females: 88 - 0.7 (A - 20) / Scr; where A = age in yrs; CLcr = creatinine clearance in mL/min/1.73 m^2","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9909C965-BD63-6DD1-E053-F662850AAC34","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-12-06","modifiedBy":"ONEDATA","dateModified":"2019-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2EDFC95-CAE6-37D0-E053-F662850A69E3","beginDate":"2019-12-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","deletedIndicator":"No"},{"value":"FIBROMETER FORMULA","valueDescription":"Fibrometer Formula","ValueMeaning":{"publicId":"7351554","version":"1","preferredName":"Fibrometer Formula","longName":"7351554","preferredDefinition":"A formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age. Fibrometer regression function = -0.007 platelets (Giga/L) - 0.049 prothrombin index (%) + 0.012 aspartate aminotransferase (UI/L) + 0.005 alpha2-macroglobulin (mg/dL) + 0.021 hyaluronate (g/L) - 0.270 urea (mmol/L) + 0.027 age (years) + 3.718. (Cales P, Oberti F, Michalak S et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005 Dec;42(6):1373-81.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrometer Formula","conceptCode":"C172489","definition":"A formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age. Fibrometer regression function = -0.007 platelets (Giga/L) - 0.049 prothrombin index (%) + 0.012 aspartate aminotransferase (UI/L) + 0.005 alpha2-macroglobulin (mg/dL) + 0.021 hyaluronate (g/L) - 0.270 urea (mmol/L) + 0.027 age (years) + 3.718. (Cales P, Oberti F, Michalak S et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005 Dec;42(6):1373-81.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-49F5-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA56C318-4A0E-19EA-E053-4EBD850AE8EF","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"HEPASCORE FORMULA","valueDescription":"Hepascore Formula","ValueMeaning":{"publicId":"7351556","version":"1","preferredName":"Hepascore Formula","longName":"7351556","preferredDefinition":"A formula that estimates liver pathology through the assessment of a four-parameter blood test, taking into account subject age and sex. Hepascore = y/(1 + y) with y = exp (-4.185818 - (0.0249 x age) + (0.7464 x 1 if male, 0 if female gender) + (1.0039 x a2 macroglobulin) + (0.0302 x hyaluronate) + (0.0691 x bilirubin) - (0.0012 x gamma-glutamyl transferase)). (Adams LA, Bulsara M, Rossi E et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005 Oct;51(10):1867-73.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepascore Formula","conceptCode":"C172488","definition":"A formula that estimates liver pathology through the assessment of a four-parameter blood test, taking into account subject age and sex. Hepascore = y/(1 + y) with y = exp (-4.185818 - (0.0249 x age) + (0.7464 x 1 if male, 0 if female gender) + (1.0039 x a2 macroglobulin) + (0.0302 x hyaluronate) + (0.0691 x bilirubin) - (0.0012 x gamma-glutamyl transferase)). (Adams LA, Bulsara M, Rossi E et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem. 2005 Oct;51(10):1867-73.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-4A1B-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA56C318-4A34-19EA-E053-4EBD850AE8EF","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"NASH FIBROSURE FORMULA","valueDescription":"NASH Fibrosure Formula","ValueMeaning":{"publicId":"7351558","version":"1","preferredName":"NASH Fibrosure Formula","longName":"7351558","preferredDefinition":"A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and non-alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, gender, height, and weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NASH Fibrosure Formula","conceptCode":"C172487","definition":"A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and non-alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, gender, height, and weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-4A41-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA56C318-4A5A-19EA-E053-4EBD850AE8EF","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"ASH FIBROSURE FORMULA","valueDescription":"ASH Fibrosure Formula","ValueMeaning":{"publicId":"7351560","version":"1","preferredName":"ASH Fibrosure Formula","longName":"7351560","preferredDefinition":"A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, gender, height, and weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ASH Fibrosure Formula","conceptCode":"C172486","definition":"A proprietary algorithm derived from the FibroTest liver fibrosis algorithm that is used to measure liver fibrosis, hepatic steatosis, and alcoholic steatohepatitis. It includes ten serum markers: alpha-2-macroglobulin, apolipoprotein A1, total bilirubin, gamma-glutamyltransferase, haptoglobin, alanine aminotransferase, aspartate aminotransferase, glucose, total cholesterol, and triglycerides, and adjusts for age, gender, height, and weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-4A67-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA56C318-4A80-19EA-E053-4EBD850AE8EF","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"FIBROTEST FORMULA","valueDescription":"Fibrotest Formula","ValueMeaning":{"publicId":"7351562","version":"1","preferredName":"Fibrotest Formula","longName":"7351562","preferredDefinition":"A formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age and sex. z = 4.467 x log10[Alpha2-Macroglobulin(g/L)] - 1.357 x log10[Haptoglobulin(g/L) + 1.017 x log10[Gamma Glutamyl Transferase (IU/L)] +0.0281 x [Age] + 1.737 x log10[Bilirubin umol/L] - 1.184 x [Apolipoprotein A1(g/L)] + 0.301 x [Sex (female=0, Male=1) - 5.54. (US Patent 6631330)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrotest Formula","conceptCode":"C172485","definition":"A formula that estimates liver pathology through the assessment of a six-parameter blood test, taking into account subject age and sex. z = 4.467 x log10[Alpha2-Macroglobulin(g/L)] - 1.357 x log10[Haptoglobulin(g/L) + 1.017 x log10[Gamma Glutamyl Transferase (IU/L)] +0.0281 x [Age] + 1.737 x log10[Bilirubin umol/L] - 1.184 x [Apolipoprotein A1(g/L)] + 0.301 x [Sex (female=0, Male=1) - 5.54. (US Patent 6631330)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA56C318-4A8D-19EA-E053-4EBD850AE8EF","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA56C318-4AA6-19EA-E053-4EBD850AE8EF","beginDate":"2020-07-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"GMI MMOL/MOL FORMULA","valueDescription":"Glucose Management Indicator Mmol/mol Formula","ValueMeaning":{"publicId":"7463265","version":"1","preferredName":"Glucose Management Indicator Mmol/mol Formula","longName":"7463265","preferredDefinition":"A formula to calculate the glucose management indicator (GMI) in mmol/mol. GMI = 12.71 + 4.70587 x [mean glucose in mmol/L]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucose Management Indicator Mmol/mol Formula","conceptCode":"C174290","definition":"A formula to calculate the glucose management indicator (GMI) in mmol/mol. GMI = 12.71 + 4.70587 x [mean glucose in mmol/L]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1797ADB-545B-33AF-E053-4EBD850A8609","latestVersionIndicator":"Yes","beginDate":"2020-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-10-12","modifiedBy":"ONEDATA","dateModified":"2020-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1797ADB-5474-33AF-E053-4EBD850A8609","beginDate":"2020-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-10-12","modifiedBy":"ONEDATA","dateModified":"2020-10-12","deletedIndicator":"No"},{"value":"GMI % FORMULA","valueDescription":"Glucose Management Indicator Percentage Formula","ValueMeaning":{"publicId":"7463267","version":"1","preferredName":"Glucose Management Indicator Percentage Formula","longName":"7463267","preferredDefinition":"A formula to calculate the glucose management indicator (GMI) as a percentage. GMI = 3.31 + 0.02392 x [mean glucose in mg/dL]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glucose Management Indicator Percentage Formula","conceptCode":"C174289","definition":"A formula to calculate the glucose management indicator (GMI) as a percentage. GMI = 3.31 + 0.02392 x [mean glucose in mg/dL]. (Richard M. Bergenstal, Roy W. Beck, Kelly L. Close, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018 Nov; 41(11): 2275-2280.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1797ADB-5481-33AF-E053-4EBD850A8609","latestVersionIndicator":"Yes","beginDate":"2020-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-10-12","modifiedBy":"ONEDATA","dateModified":"2020-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1797ADB-549A-33AF-E053-4EBD850A8609","beginDate":"2020-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-10-12","modifiedBy":"ONEDATA","dateModified":"2020-10-12","deletedIndicator":"No"},{"value":"DAF","valueDescription":"Diamandopoulos' A. formula","ValueMeaning":{"publicId":"7245308","version":"1","preferredName":"Diamandopoulos' A. formula","longName":"7245308","preferredDefinition":"A formula for estimating creatinine clearance, defined as Ccr=80/Scr (70 for females).\r\n\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diamandopoulos' A. formula","conceptCode":"C171195","definition":"A formula for estimating creatinine clearance, defined as Ccr=80/Scr (70 for females).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B3709-7AB8-2C30-E053-F662850ACC31","latestVersionIndicator":"Yes","beginDate":"2020-04-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-13","modifiedBy":"ONEDATA","dateModified":"2020-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C10DECB3-6EC4-3068-E053-4EBD850AFB36","beginDate":"2020-04-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-04-28","modifiedBy":"ONEDATA","dateModified":"2021-04-28","deletedIndicator":"No"},{"value":"IDMS-MDRD STUDY EQUATION WITH JSN-CKDI COEFFICIENT 0.741 IMAI 2007","valueDescription":"IDMS-MDRD Study Equation With JSN-CKDI Coefficient 0.741 Imai et al. 2007","ValueMeaning":{"publicId":"7797865","version":"1","preferredName":"IDMS-MDRD Study Equation With JSN-CKDI Coefficient 0.741 Imai et al. 2007","longName":"7797865","preferredDefinition":"A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (mL/min/1.73 m2) = 0.741 x SCr^-1.154 x 175 x Age^-0.203 x 0.742 (if female). (Enyu Imai, Masaru Horio, Kosaku Nitta, Kunihiro Yamagata, Kunitoshi Iseki, Yusuke Tsukamoto, Sadayoshi Ito, Hirofumi Makino, Akira Hishida, Seiichi Matsuo. Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IDMS-MDRD Study Equation With JSN-CKDI Coefficient 0.741 Imai et al. 2007","conceptCode":"C181401","definition":"A formula to estimate glomerular filtration rate in Japanese subjects that takes into account age, sex, and serum creatinine. eGFR (mL/min/1.73 m2) = 0.741 x SCr^-1.154 x 175 x Age^-0.203 x 0.742 (if female). (Enyu Imai, Masaru Horio, Kosaku Nitta, Kunihiro Yamagata, Kunitoshi Iseki, Yusuke Tsukamoto, Sadayoshi Ito, Hirofumi Makino, Akira Hishida, Seiichi Matsuo. Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan. Am J Kidney Dis. 2007 Dec;50(6):927-37.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE2DC02C-19C0-71E9-E053-4EBD850ABC2F","latestVersionIndicator":"Yes","beginDate":"2021-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-12","modifiedBy":"ONEDATA","dateModified":"2021-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CE2DC02C-19D9-71E9-E053-4EBD850ABC2F","beginDate":"2021-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-10-12","modifiedBy":"ONEDATA","dateModified":"2021-10-12","deletedIndicator":"No"},{"value":"FIBROSIS 4 FORMULA","valueDescription":null,"ValueMeaning":{"publicId":"11106725","version":"1","preferredName":"Fibrosis 4 Formula","longName":"11106725v1.00","preferredDefinition":"A formula that estimates liver pathology through the assessment of a three-parameter blood test, taking into account subject age. FIB-4 = age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). (Sterling RK, Lissen E, Clumeck N, et. al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology 2006;43:1317-1325.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis 4 Formula","conceptCode":"C170576","definition":"A formula that estimates liver pathology through the assessment of a three-parameter blood test, taking into account subject age. FIB-4 = age ([yr] x AST [U/L]) / ((PLT [10(9)/L]) x (ALT [U/L])(1/2)). (Sterling RK, Lissen E, Clumeck N, et. al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co-infection. Hepatology 2006;43:1317-1325.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E65D0C40-64DA-2CE6-E053-731AD00A188B","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-16","modifiedBy":"KUMMEROA","dateModified":"2022-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E65D0C40-64DC-2CE6-E053-731AD00A188B","beginDate":"2022-08-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-16","modifiedBy":"KUMMEROA","dateModified":"2022-08-16","deletedIndicator":"No"},{"value":"MDRD FORMULA","valueDescription":null,"ValueMeaning":{"publicId":"11106726","version":"1","preferredName":"Modification of Diet in Renal Disease Formula","longName":"11106726v1.00","preferredDefinition":"An unspecified Modification of Diet in Renal Disease-based formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modification of Diet in Renal Disease Formula","conceptCode":"C176295","definition":"An unspecified Modification of Diet in Renal Disease-based formula to estimate glomerular filtration rate that takes into account factors such as sex, age, race, and biomarker measurements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E65D0C40-64DB-2CE6-E053-731AD00A188B","latestVersionIndicator":"Yes","beginDate":"2022-08-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-16","modifiedBy":"KUMMEROA","dateModified":"2022-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E65D0C40-64DD-2CE6-E053-731AD00A188B","beginDate":"2022-08-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-08-16","modifiedBy":"KUMMEROA","dateModified":"2022-08-16","deletedIndicator":"No"},{"value":"NEPHROCHECK AKI RISK 2013 FORMULA","valueDescription":null,"ValueMeaning":{"publicId":"14685873","version":"1","preferredName":"NephroCheck AKI Risk 2013 Formula","longName":"14685873v1.00","preferredDefinition":"A proprietary algorithm derived from the NephroCheck test that is used for the risk assessment of moderate or severe acute kidney injury. It includes two urine markers: insulin-like growth factor binding protein 7 (IGFBP-7) and tissue inhibitor of metalloproteinase 2 (TIMP-2). (Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013 Feb 6;17(1):R25.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NephroCheck AKI Risk 2013 Formula","conceptCode":"C202375","definition":"A proprietary algorithm derived from the NephroCheck test that is used for the risk assessment of moderate or severe acute kidney injury. It includes two urine markers: insulin-like growth factor binding protein 7 (IGFBP-7) and tissue inhibitor of metalloproteinase 2 (TIMP-2). (Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013 Feb 6;17(1):R25.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F39BAD6-A77A-25A0-E063-731AD00A9B69","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F39BAD6-A77B-25A0-E063-731AD00A9B69","beginDate":"2024-01-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-18","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7244862","version":"1","preferredName":"CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology Clinical Study Sponsor Defined Name","preferredDefinition":"Terminology associated with the laboratory analytical method calculation formula codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"C160922:C70793:C165683:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology","conceptCode":"C160922","definition":"Terminology associated with the laboratory analytical method calculation formula codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2EDFC95-CA1F-37D0-E053-F662850A69E3","latestVersionIndicator":"Yes","beginDate":"2020-04-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"ONEDATA","dateModified":"2020-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2EDFC95-CA30-37D0-E053-F662850A69E3","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-04-10","modifiedBy":"KUMMEROA","dateModified":"2024-01-18","changeDescription":"2021-10-12 ak Updated to CT Package 47 release.2020-10-12 ak Updated to CT Package 43 release. 2020-7-14 ak Updated to CT Package 42 release.  4-10-20 tmt versioned per replacement of 1 PV and changes to Long and Short Name. 112-6-19 tmt added values to PV.  1-26-19 added 1 PV/YL, MC. 10-7-19 released/mm.  10-3-19 Created for Theradex/custom CDISC request; tmt.","administrativeNotes":"2024.1.18 Updated to CT Package 56 release. ak 2022.8.16 Reviewed and changed RS from 'Incomplete' to 'Application'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology","type":"VALID_VALUE_SOURCE","description":"Terminology associated with the laboratory analytical method calculation formula codelist of the Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM).","url":"https://ncit.nci.nih.gov/ncitbrowser/ajax?action=create_src_vs_tree&amp;vsd_uri=http%3A//evs.nci.nih.gov/valueset/CDISC/C160922","context":"Theradex"},{"name":"Analysis Method","type":"Preferred Question Text","description":"Analysis Method","url":null,"context":"Theradex"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD451EF4-D07A-385D-E053-4EBD850AF1DE","latestVersionIndicator":"Yes","beginDate":"2019-10-03","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-03-11","modifiedBy":"KUMMEROA","dateModified":"2022-08-16","changeDescription":"3/11/21 TL versioned / v2 VD.","administrativeNotes":"2022.8.16 Reviewed and changed RS from 'Incomplete' to 'Application'. ak","unresolvedIssues":null,"deletedIndicator":"No"}}